Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Behjatolah Monzavi-Karbassi, Fariba Jousheghany & Thomas Kieber-Emmons. (2016) Tumor-associated Glycans and Tregs in Immunogenicity of an Autologous Cell-based Vaccine. Immunological Investigations 45:8, pages 746-758.
Read now
Read now
Articles from other publishers (4)
Roberto Raúl Servin-Garrido, Damaris Ilhuicatzi-Alvarado, Ángel de Jesús Jiménez-Chávez & Leticia Moreno-Fierros. (2022) Cry1Ac Protoxin Confers Antitumor Adjuvant Effect in a Triple-Negative Breast Cancer Mouse Model by Improving Tumor Immunity. Breast Cancer: Basic and Clinical Research 16, pages 117822342110651.
Crossref
Crossref
Hanie Mahaki, Mohammad Hadi Saeed Modaghegh, Zeynab Nasr Isfahani, Rahele Amir Daddost, Pejman Molaei, Yaghoub Ahmadyousefi, Masoomeh Vahidzadeh, Elham Lotfiane & Hamid Tanzadehpanah. (2021) The Role of Peptide-Based Tumor Vaccines on Cytokines of Adaptive Immunity: A Review. International Journal of Peptide Research and Therapeutics 27:4, pages 2527-2542.
Crossref
Crossref
Benjamin Gordon & Vijayakrishna K. Gadi. (2020) The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines. Vaccines 8:3, pages 529.
Crossref
Crossref
Alexey V. Baldin, Lyudmila V. Savvateeva, Alexandr V. Bazhin & Andrey A. ZamyatninJr.Jr.. (2020) Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting. Cancers 12:3, pages 590.
Crossref
Crossref